Cargando…
Initial use of voriconazole positively affects outcome of Candida parapsilosis bloodstream infection: a retrospective analysis
BACKGROUND: Concerns have arisen regarding the optimal antifungal regimen for Candida parapsilosis (C. parapsilosis) bloodstream infection (BSI) in view of its reduced sensitivity to fluconazole. METHODS: The clinical characteristics of 58 C. parapsilosis BSI newborns who received treatment between...
Autores principales: | Wu, Yejuan, Wei, Dong, Gong, Xiaohui, Shen, Yunlin, Zhu, Yingying, Wang, Junfang, Gao, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475306/ https://www.ncbi.nlm.nih.gov/pubmed/32953545 http://dx.doi.org/10.21037/tp-20-37 |
Ejemplares similares
-
Successful Treatment of Candida parapsilosis Fungemia in Two Preterms with Voriconazole
por: Altuncu, Emel, et al.
Publicado: (2015) -
Successful treatment of Candida parapsilosis mural endocarditis with combined caspofungin and voriconazole
por: López-Ciudad, Víctor, et al.
Publicado: (2006) -
Concurrent bloodstream infection with Lodderomyces elongisporus and Candida parapsilosis
por: Koh, Bryant, et al.
Publicado: (2020) -
Risk Factors of Candida parapsilosis Catheter-Related Bloodstream Infection
por: Yamin, Dina Hussein, et al.
Publicado: (2021) -
Factors related to outcome of bloodstream infections due to Candida parapsilosis complex
por: Barchiesi, Francesco, et al.
Publicado: (2016)